Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The Collective Investment Scheme (CIS) operated through the Growpital platform prima facie violates provisions of the SEBI Act, CIS Regulations, and SEBI-PFUTP Regulations. The activities indicate an unregistered CIS mobilizing over Rs. 132 crore in ZF Project 1 LLP alone, amounting to a fraudulent practice under Regulation 4(2)(t) of PFUTP Regulations. To safeguard investors' interests, an ad-interim ex-parte order directs Growpital and its directors/partners to cease soliciting or undertaking CIS activities, not collect funds, not divert existing funds, not dispose assets without SEBI's permission, provide asset inventory, remove CIS-related materials, not access securities market, and submit investor details. Cashfree Payments, banks, depositories, and RTAs are directed to freeze accounts and disallow transfers. The order aims to prevent further fund mobilization through the unregistered platform.
The Collective Investment Scheme (CIS) operated through the Growpital platform prima facie violates provisions of the SEBI Act, CIS Regulations, and SEBI-PFUTP Regulations. The activities indicate an unregistered CIS mobilizing over Rs. 132 crore in ZF Project 1 LLP alone, amounting to a fraudulent practice under Regulation 4(2)(t) of PFUTP Regulations. To safeguard investors' interests, an ad-interim ex-parte order directs Growpital and its directors/partners to cease soliciting or undertaking CIS activities, not collect funds, not divert existing funds, not dispose assets without SEBI's permission, provide asset inventory, remove CIS-related materials, not access securities market, and submit investor details. Cashfree Payments, banks, depositories, and RTAs are directed to freeze accounts and disallow transfers. The order aims to prevent further fund mobilization through the unregistered platform.
Note: It is a system-generated summary and is for quick reference only.